14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 7 days ( 0 % )
Last Price $108.24 0 %
High/ Low $108.24 - $108.24 0%
Chg 7 Days N/A $108.24 $108.24
Chg 30 Days N/A $108.24 $108.24
Chg 12 mos 23.99 % $87.30 $108.24
Trend - 3 mos 2.33 % Width: 3.38 %
Trend - 12 mos 24.46 % Width: 13.62 %
Pred. range - 3 mos $111.04 - $114.80 2.59 % - 6.06 %
Pred. range - 12 mos $125.16 - $142.20 15.63 % - 31.38 %
Short MA avg 3 mos Buy Nov 26, 2019 - 35 days
Long MA avg 3 mos Buy Jan 08, 2020 - 7 days
Short/Long MA avg 3 mos Buy Jan 08, 2020 - 7 days
Short MA avg 12 mos Buy Dec 04, 2019 - 30 days
Long MA avg 12 mos Sell Aug 22, 2019 - 102 days
Short/Long MA avg 12 mos Buy Aug 20, 2019 - 104 days
Pivot Short Sell Nov 19, 2019 - 40 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Celgene Corporation

Celgene Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID to treat multiple myeloma; and OTEZLA, a small-molecule inhib... CELG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT